Trials / Conditions / Intra-abdominal Infection

Intra-abdominal Infection

22 registered clinical trials studyying Intra-abdominal Infection — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Rezafungin Peritoneal Diffusion for Intra-abdominal Candidiasis NCT07093203	Central Hospital, Nancy, France	—
Recruiting	Innate Immune Response Monitoring Via Monocyte HLA-DR in Severe Intra-abdominal Infections at Risk of Fungal I NCT07130799	Central Hospital, Nancy, France	—
Completed	Diagnostic Performance of the CandID PLUS PCR for the Diagnosis of Intra-abdominal Candidiasis in Critically I NCT07005258	Central Hospital, Nancy, France	—
Completed	Performance of the SeptiCyte LAB Test for Antibiotic Stewardship in Mesenteric Ischemia NCT06507423	Central Hospital, Nancy, France	—
Active Not Recruiting	The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patient NCT06304779	Shanghai Zhongshan Hospital	N/A
Completed	Hellenic Registry for cIAIs (HERCO-II) NCT05549076	Maximos Frountzas	—
Active Not Recruiting	The PASTDUe Nutrition Ecosystem Project (PASTDUe) NCT05127109	Duke University	Phase 4
Completed	Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chin NCT04882085	Pfizer	Phase 4
Unknown	Study for Rapid Diagnosis of Postoperative Abdominal Infection NCT05187871	Peking Union Medical College Hospital	—
Suspended	The Optimization of a Low-dose CT Protocol in Patients With Suspected Uncomplicated Acute Appendicitis and BMI NCT04519086	Turku University Hospital	N/A
Unknown	Development of Risk Score Model and Decision Tree Algorithm for Predicting Infections With CRKp in Colonized P NCT04229511	SCARE (Study group for carbapenem resistance)	—
Completed	Study of Ceftolozane/Tazobactam (MK-7625A) in Combination With Metronidazole in Japanese Participants With Com NCT02739997	Merck Sharp & Dohme LLC	Phase 3
Completed	The Optimization of a Low-dose Computed Tomography Protocol in Patients With Suspected Uncomplicated Acute App NCT02533869	Turku University Hospital	N/A
Completed	A Study To Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complic NCT01721408	Pfizer	Phase 4
Completed	A Comparative Study of Ampicillin/Sulbactam Versus Moxifloxacin in the Treatment of Complicated Intra-abdomina NCT00952796	Kaohsiung Medical University Chung-Ho Memorial Hospital	Phase 4
Completed	Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections NCT00621192	The Emmes Company, LLC	Phase 1 / Phase 2
Completed	T.E.A. Study Three Days Ertapenem Versus Three Days Ampicillin- Sulbactam NCT00630513	University of Bologna	Phase 4
Completed	Autologous Fibrin Glues for Fistulas Closure NCT01561066	Jinling Hospital, China	Phase 1
Completed	Study Evaluating the Pharmacokinetics (PK), Safety, and Tolerability of Tigecycline in Patients 8 to 11 Years NCT00488345	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 2
Completed	Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infect NCT00230971	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 4
Completed	Study Evaluating the Etiology of Intra-Abdominal Infections NCT00244088	Wyeth is now a wholly owned subsidiary of Pfizer	—
Completed	A Study to Evaluate the Safety and Effectiveness of Ertapenem Versus Ceftriaxone/Metronidazole in the Treatmen NCT00481702	Merck Sharp & Dohme LLC	Phase 3